Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Figure 5 | Journal of Neuroinflammation

Figure 5

From: Passive immunotherapy against Aβ in aged APP-transgenic mice reverses cognitive deficits and depletes parenchymal amyloid deposits in spite of increased vascular amyloid and microhemorrhage

Figure 5

Number of Prussian blue-positive profiles increases with duration of anti-Aβ antibody exposure. The graph shows quantification of the average number of Prussian blue-positive profiles per section from mice administered control IgG for 3 or 5 months (Cont) or anti-Aβ IgG for 1, 2, 3 or 5 months (anti-Aβ). ** p < 0.01.

Back to article page